| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/30/2007 | EP1278517B1 Methods for improving size and appearance of a wound |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/30/2007 | EP1263723B1 Ningalin b analogs employable for reversing multidrug resistance |
| 05/30/2007 | EP1257537B1 Therapeutic morpholino-substituted compounds |
| 05/30/2007 | EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/30/2007 | EP1180103B1 Renin inhibitors |
| 05/30/2007 | EP1171165B1 Intramyocardial injection of autologous bone marrow |
| 05/30/2007 | EP1169037B1 Use of pioglitazone for improving ketosis and acidosis |
| 05/30/2007 | EP1117667B1 BENZOTHIENO[3,2-c]PYRIDINES AS ALPHA2 ANTAGONISTS |
| 05/30/2007 | EP1091742A4 Indium photosensitizers for pdt |
| 05/30/2007 | EP1074255B1 Pharmaceutical gel formulation comprising a tricyclic compound (fk-506/tacrolimus) |
| 05/30/2007 | EP1062954B1 Use of itaconic acid for regulation of glycolytic metabolism |
| 05/30/2007 | EP0975754B1 Osteoprotegerin binding proteins and receptors |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | EP0904367B1 Scf analog compositions and methods |
| 05/30/2007 | EP0819121B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/30/2007 | CN2905051Y A precharged preparation of antibacterial drug |
| 05/30/2007 | CN1972955A Radiosensitizer |
| 05/30/2007 | CN1972949A Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 05/30/2007 | CN1972946A 7h-pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for production the active agent |
| 05/30/2007 | CN1972945A Selective antagonists of A2A adenosine receptors |
| 05/30/2007 | CN1972944A Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 05/30/2007 | CN1972943A New derivatives of 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxamide or 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxylic acid |
| 05/30/2007 | CN1972942A Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 05/30/2007 | CN1972941A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as CRF antagonists |
| 05/30/2007 | CN1972940A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists |
| 05/30/2007 | CN1972938A 环状胺化合物 Cyclic amine compound |
| 05/30/2007 | CN1972937A Neuropeptide receptor modulators |
| 05/30/2007 | CN1972936A Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure |
| 05/30/2007 | CN1972935A Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient |
| 05/30/2007 | CN1972934A 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 05/30/2007 | CN1972931A Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia |
| 05/30/2007 | CN1972930A Novel pyridazinone derivatives as inhibitors of CDK2 |
| 05/30/2007 | CN1972929A Heterocyclic CGRP antagonists for the treatment of migraine |
| 05/30/2007 | CN1972928A New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt |
| 05/30/2007 | CN1972927A Compounds and methods for treating dyslipidemia |
| 05/30/2007 | CN1972926A Indole derivatives as histamine receptor antagonists |
| 05/30/2007 | CN1972925A Substituted bisarylurea derivatives |
| 05/30/2007 | CN1972924A Novel compounds |
| 05/30/2007 | CN1972923A Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 05/30/2007 | CN1972921A 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 05/30/2007 | CN1972920A Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms |
| 05/30/2007 | CN1972919A Method for producing 4-(benzimidazolylmethylamino)-benzamidines |
| 05/30/2007 | CN1972918A 嘧啶衍生物 Pyrimidine derivatives |
| 05/30/2007 | CN1972916A 肉桂酰胺类化合物 Cinnamic amides |
| 05/30/2007 | CN1972914A Non-imidazole heterocyclic compounds as histamine H3-receptor ligands |
| 05/30/2007 | CN1972913A Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
| 05/30/2007 | CN1972912A Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives |
| 05/30/2007 | CN1972911A 2-(1h-indolylsulfanyl)-aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
| 05/30/2007 | CN1972910A 内酰胺速激肽受体拮抗剂 Lactam tachykinin receptor antagonists |
| 05/30/2007 | CN1972909A Thio-substituted arylmethanesulfinyl derivatives |
| 05/30/2007 | CN1972908A N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 05/30/2007 | CN1972907A Sulfonamide compound |
| 05/30/2007 | CN1972903A 新的mao－b抑制剂 New mao-b inhibitor |
| 05/30/2007 | CN1972897A Novel hexafluoroisopropanol derivatives |
| 05/30/2007 | CN1972745A Adsorbent and manufacturing method therefor |
| 05/30/2007 | CN1972730A Glycopyrrolate for treating childhood asthma |
| 05/30/2007 | CN1972716A Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 05/30/2007 | CN1972715A Therapeutic agent for diabetes mellitus containing insulin resistance improving agent |
| 05/30/2007 | CN1972708A Compositions for topical treatment |
| 05/30/2007 | CN1972707A Treatment of conditions involving demyelination |
| 05/30/2007 | CN1972702A Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 05/30/2007 | CN1972701A Appetite-suppressing compositions and methods |
| 05/30/2007 | CN1972698A Beta-hydroxy short to medium chain fatty acid polymer |
| 05/30/2007 | CN1972697A Compounds and methods for treating seizure disorders |
| 05/30/2007 | CN1972696A Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection |
| 05/30/2007 | CN1972695A Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones |
| 05/30/2007 | CN1972694A Antibiotics containing borinic acid complexes and methods of use |
| 05/30/2007 | CN1972693A Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology |
| 05/30/2007 | CN1972692A Compositions and methods for treatment of premenstrual dysphoric disorder |
| 05/30/2007 | CN1972691A Intranasal benzodiazepine compositions |
| 05/30/2007 | CN1972690A Use of meloxicam in veterinary medicine for the treatment of inflammatory painful diseases |
| 05/30/2007 | CN1972689A Solid orally ingestible formulations of tetrodotoxin |
| 05/30/2007 | CN1972688A 4-phenylamino-quinazolin-6-yl-amides |
| 05/30/2007 | CN1972687A Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties |
| 05/30/2007 | CN1972686A Uses of selective cytokine inhibitory drugs in myelodysplastic syndromes |
| 05/30/2007 | CN1972685A Compositions and methods to treat recurrent medical conditions |
| 05/30/2007 | CN1972684A Methods of using and compositions comprising PDE4 modulators for the treatment and management of pulmonary hypertension |
| 05/30/2007 | CN1972683A Composition comprising lactic acid and lactoferrin |
| 05/30/2007 | CN1972682A Metabolites of selective androgen receptor modulators and methods of use thereof |
| 05/30/2007 | CN1972681A System and method for transdermal delivery of an anticoagulant |
| 05/30/2007 | CN1972680A Method for treatment or prevention of osteoporosis in individuals with high bone turnover |
| 05/30/2007 | CN1972679A Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1-receptor antagonists |
| 05/30/2007 | CN1972678A Steroid intraocular implants having an extended sustained release for a period of greater than two months |
| 05/30/2007 | CN1972677A Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| 05/30/2007 | CN1972676A Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens |
| 05/30/2007 | CN1972672A Non-animal product-containing veterinary formulations |
| 05/30/2007 | CN1972666A OROS push-stick for controlled delivery of active agents |
| 05/30/2007 | CN1972665A Injectable depot compositions and uses thereof |
| 05/30/2007 | CN1972661A Use of furan alkyls for a cellulite cosmetic treatment |
| 05/30/2007 | CN1972604A Improvement of barrier integrity in HIV patients |
| 05/30/2007 | CN1970778A 碳水化合物 Carbohydrates |
| 05/30/2007 | CN1970590A Solid polymer prepared by contacting between polymer hydrogel and solvent |
| 05/30/2007 | CN1970579A High substitution degree carboxymethyl indianbread polysaccharide and its preparation method and uses |
| 05/30/2007 | CN1970577A Zinc-enriched Armillariella tabescens Polysaccharide and its preparation and use |
| 05/30/2007 | CN1970576A Extraction and preparation process of polysaccharide of Pteris semipinnata L. with anticancer activity |
| 05/30/2007 | CN1970559A Beta-carboline alkaloid, their preparation method and use |
| 05/30/2007 | CN1970557A Itraconazole mesylate and its composition and preparation method |
| 05/30/2007 | CN1970556A 1-furfuryl-3-substituted Indolinyl-2-one derivative, its preparation method and uses |
| 05/30/2007 | CN1970552A Substituted[1,3,5] triazine compound, its preparing process and its application |